Cannabis Central: Sector Down 45% YTD With Only These 2 Pot Stocks Increasing In Price
TM editors' note: This article discusses a penny stock and/or microcap. Such stocks are easily manipulated; do your own careful due diligence.
The non-penny pot stock sector of 37 stocks is down 21.7% year-to-date which, as terrible as that certainly is, is better than the cannabis sector as a whole (319 stocks) which is down 45.5% year-to-date. This article identifies the 4 winners and 8 big losers of the past 3 months plus the performance of 6 other pot stocks worthy of mention.
Of the 37 stocks analyzed only 2 stocks have increased in price so far this year while 2 others showed no change and the remaining 33 declined anywhere from 11.8% to 66.8%. In fact, 8 of the stocks declined by 50% or more during that time. To put things in perspective the S&P 500 has declined 19% YTD.
The Winners were:
- XPhyto (XPHYF) +156.3%
- Innovative Properties (IIPR) +3.0%
- Corbus (CRBP) +/-0%
- GrowGeneration (GRWG) +/-0%
The Big Losers were:
- Pyxus Int'l (PYX) -66.8%
- Harvest Health (HRVSF) -66.5%
- Acreage (ACRGF) -60.6%
- Alcanna (LQSIF) -58.9%
- Tilray (TLRY) -57.3%
- Aurora (ACB) -57.0%
- Cresco (CRLBF) -50.5%
- Neptune (NEPT) -50.0%
Notable Mentions
- Village Farms (VFF) -39.5%
- Aphria (APHA) -31.6%
- Hexo (HEXO) -30.9%
- Valens (VLNSF) -30.0%
- Canopy (CGC) -21.6%
- Cronos (CRON) -11.8%
The above being said the sector has advanced each of the last 5 trading days which is perhaps establishing the foundation for a much-improved performance over the balance of the year. Time will tell.
This article may discuss small-, micro- and nano-cap stocks so do your own careful due diligence. Visit more
How do you think the pandemic will affect the cannabis industry?
Yes, absolutely! The sector is not immune to general market sentiment, social distancing which will restrict traffic into pot dispensaries and unemployment which will reduce the amount of money available to buy such products. In turn, cash flow for these companies will suffer further and none of the above realities will positively impact their stock prices.